Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, California.
Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, California; G Oppenheimer Center for Neurobiology of Stress and Resilience, Los Angeles, California.
Clin Gastroenterol Hepatol. 2022 Mar;20(3):e465-e483. doi: 10.1016/j.cgh.2021.05.027. Epub 2021 May 20.
BACKGROUND & AIMS: Altered fecal microbiota have been reported in irritable bowel syndrome (IBS), although studies vary, which could be owing to dietary effects. Many IBS patients may eliminate certain foods because of their symptoms, which in turn may alter fecal microbiota diversity and composition. This study aimed to determine if dietary patterns were associated with IBS, symptoms, and fecal microbiota differences reported in IBS. METHODS: A total of 346 IBS participants and 170 healthy controls (HCs) completed a Diet Checklist reflecting the diet(s) consumed most frequently. An exclusion diet was defined as a diet that eliminated food components by choice. Within this group, a gluten-free, dairy-free, or low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet was further defined as restrictive because they often are implicated in reducing symptoms. Stool samples were obtained from 171 IBS patients and 98 HCs for 16S ribosomal RNA gene sequencing and microbial composition analysis. RESULTS: Having IBS symptoms was associated with consuming a restrictive diet (27.17% of IBS patients vs 7.65% of HCs; odds ratio, 3.25; 95% CI, 1.66-6.75; P value = .006). IBS participants on an exclusion or restrictive diet reported more severe IBS symptoms (P = .042 and .029, respectively). The composition of the microbiota in IBS patients varied depending on the diet consumed. IBS participants on an exclusion diet had a greater abundance of Lachnospira and a lower abundance of Eubacterium (q value, <.05), and those on a restrictive diet had a lower abundance of Lactobacillus (q value, <.05). CONCLUSIONS: Restrictive diets likely are consumed more by IBS patients than HCs to reduce GI symptom severity. Dietary patterns influence the composition of the fecal microbiota and may explain some of the differences between IBS and HCs.
背景与目的:虽然已有研究报道肠易激综合征(IBS)患者粪便微生物群发生改变,但结果存在差异,这可能与饮食因素有关。许多 IBS 患者可能会因为自身症状而避免某些食物,这反过来又可能改变粪便微生物群的多样性和组成。本研究旨在确定饮食模式是否与 IBS 相关,以及与 IBS 患者报告的症状和粪便微生物群差异相关。
方法:共有 346 名 IBS 患者和 170 名健康对照者(HCs)完成了反映最常食用饮食的饮食清单。排除饮食是指通过选择消除食物成分的饮食。在这组人群中,无麸质、无乳制品或低发酵寡糖、双糖、单糖和多元醇饮食进一步定义为限制饮食,因为它们通常与减轻症状有关。从 171 名 IBS 患者和 98 名 HCs 中获得粪便样本,用于 16S 核糖体 RNA 基因测序和微生物组成分析。
结果:存在 IBS 症状与食用限制饮食有关(27.17%的 IBS 患者与 7.65%的 HCs;比值比,3.25;95%CI,1.66-6.75;P 值=.006)。食用排除或限制饮食的 IBS 患者报告的 IBS 症状更严重(P 值分别为.042 和.029)。根据所食用的饮食,IBS 患者的微生物群组成有所不同。食用排除饮食的 IBS 患者的 Lachnospira 丰度更高,Eubacterium 丰度更低(q 值<.05),而食用限制饮食的 IBS 患者的 Lactobacillus 丰度更低(q 值<.05)。
结论:与 HCs 相比,限制饮食可能更多地被 IBS 患者所采用,以减轻胃肠道症状的严重程度。饮食模式会影响粪便微生物群的组成,并且可能解释 IBS 与 HCs 之间的一些差异。
Clin Gastroenterol Hepatol. 2022-3
Gastroenterology. 2013-9-25
Korean J Gastroenterol. 2022-7-25
Front Microbiol. 2024-10-24
Gut Microbiome (Camb). 2022-8-25
Ir J Med Sci. 2024-12
J Clin Med. 2024-2-26
Neurogastroenterol Motil. 2024-1
Clin Gastroenterol Hepatol. 2024-1
Gut Microbes. 2023
Am J Gastroenterol. 2021-1-1
Front Endocrinol (Lausanne). 2020-1-31
Gastroenterology. 2019-3-30
mSystems. 2019-2-12
Nat Commun. 2018-11-13
Cell Mol Gastroenterol Hepatol. 2018-4-12
J Neurogastroenterol Motil. 2018-7-30